EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.22.61 | Neoplasms |
9006941 |
FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens. |
therapeutic application
unassigned |
1
0 |
| 3.4.22.61 | Molluscum Contagiosum |
9037025 |
Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. |
ongoing research
therapeutic application
unassigned |
1
1
0 |
| 3.4.22.61 | Neoplasms |
9044836 |
CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. |
unassigned |
0 |
| 3.4.22.61 | Neoplasms |
9092488 |
A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis. |
ongoing research
unassigned |
1
0 |
| 3.4.22.61 | Cowpox |
9207432 |
Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance. |
ongoing research
unassigned |
3
0 |
| 3.4.22.61 | Neoplasms |
9208847 |
Casper is a FADD- and caspase-related inducer of apoptosis. |
unassigned |
0 |
| 3.4.22.61 | Neoplasms |
9211860 |
I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. |
therapeutic application
unassigned |
1
0 |
| 3.4.22.61 | Leukemia |
9269989 |
Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells. |
unassigned |
0 |
| 3.4.22.61 | Neoplasms |
9271594 |
A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. |
unassigned |
0 |
| 3.4.22.61 | Neoplasms |
9326610 |
MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death. |
ongoing research
unassigned |
1
0 |
